Applied Dna Sciences Inc (NASDAQ:BNBX) Sees Significant Decrease in Short Interest

Applied Dna Sciences Inc (NASDAQ:BNBXGet Free Report) saw a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 55,360 shares, a decrease of 60.5% from the May 31st total of 140,122 shares. Currently, 0.8% of the company’s shares are sold short. Based on an average daily trading volume, of 236,645 shares, the short-interest ratio is currently 0.2 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Applied Dna Sciences in a research note on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Check Out Our Latest Research Report on Applied Dna Sciences

Applied Dna Sciences Trading Down 4.4%

BNBX stock traded down $0.02 during midday trading on Monday, hitting $0.37. The stock had a trading volume of 25,229 shares, compared to its average volume of 532,992. The firm has a market cap of $2.68 million, a price-to-earnings ratio of -0.01 and a beta of 0.52. The company’s fifty day moving average price is $0.47. Applied Dna Sciences has a 1-year low of $0.35 and a 1-year high of $7.15.

Applied Dna Sciences (NASDAQ:BNBXGet Free Report) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.68) earnings per share for the quarter. The business had revenue of $1.02 million during the quarter. Applied Dna Sciences had a negative return on equity of 349.95% and a negative net margin of 1,647.25%.

About Applied Dna Sciences

(Get Free Report)

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.

Featured Articles

Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.